anyway waiting for decent earnings from last Quarter will be hugely disapointed as nothing in europe will be on the books and as we know TEVA has not started selling her in the US. we might see a huge profit but it will be booked as a one time milestone payment. which is OK in my opinion. thier could be another $200mm more of that in the future. this earning will be more about the conference call and understanding the model / opps / risks / pipeline / issuances , etc. I'm looking for a nice move up to $10-12pps sooner then later. i forsee a nice left to right slope chart on the daily , weekly and monthly charts.
Agree with your assessment. The interest in the call are the specifics of the deal with Teva. The realization of the one time payment is a bigger deal for this company than many, simply because it is so large in relation to the market cap.